Vivek – First of all Thankyou
Two reasons I got of Syngene – firstly I already have 4 other pharma stocks crossing almost 24% of my portfolio – as a rule I follow that no sector should cross 25-30% exception being financials and consumers
Secondly Syngene at 350 to me seems to be pricing 3 yrs ahead of good growth so margin of safety was not there and I needed to raise cash levels to buy into Supreme Inds and Care ratings
Probably at 300 or so and when I have better cash availability I would dig into it again – I absolutely love the stock and wont advise you to sell it unless you find a much better opportunity
Tata Elxsi – I bought at 600 levels – missed at 230 odd when I first looked into –
1989 established- 25 yr old, Debt Free, 50.09 promoter share is ok, Avg ROCE of 52% is excellent, ROE of 36% is excellent, MCap < 1900 crores when invested, Theme – NICHE IT player in new technologies like Embedded product design, Industrial design (product design, branded graphics and user interface systems), VLC and systems integration, Providing software development and system design services for automotive and aerspace industry – connected cars with in vehicle infotainment, active safety systems, telematics, powertrain and hybrids as theme is a big theme, Also complete product development lifecycle from R & D to services in broadcast consumer electronics segment helping them reducing enginerring costs, Huge opportunities due to advent of Internet of things, recent addition as a core industry is healtcare with started working on medical electronics like patient monitering devices, diagnostic devices and theuraptic devices- huge growth potential, unified communications like video and audio conferencing, tele presence etc, also identified new areas like semi conductor and chip design, new theme going ahead is convergence of consumer, markets and electronics to be one of the biggest disruptive changes which will throw up lots of opportunities for Telx
| Subscribe To Our Free Newsletter |
